Cargando…

Ras-related C3 botulinum toxin substrate 1 activation is involved in the pathogenesis of diabetic retinopathy

This study used a streptozotocin (STZ)-induced rat model of diabetes to investigate whether Ras-related C3 botulinum toxin substrate 1 (Rac1) was involved in the pathogenesis of diabetic retinopathy. The effects of Rac1 inhibition on vascular endothelial (VE)-cadherin and β-catenin expression in hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, YANG-JUN, ZHANG, JIE, HAN, JING, DU, ZHAO-JIANG, WANG, PING, GUO, YONG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247314/ https://www.ncbi.nlm.nih.gov/pubmed/25452781 http://dx.doi.org/10.3892/etm.2014.2081

Ejemplares similares

Overexpression of Ras-Related C3 Botulinum Toxin Substrate 2 Radiosensitizes Melanoma Cells In Vitro and In Vivo
por: Hu, Wentao, et al.
Publicado: (2019)

Conformational landscape alternations promote oncogenic activities of Ras-related C3 botulinum toxin substrate 1 as revealed by NMR
por: Toyama, Yuki, et al.
Publicado: (2019)

Decreased conformational stability in the oncogenic N92I mutant of Ras-related C3 botulinum toxin substrate 1
por: Toyama, Yuki, et al.
Publicado: (2019)

Spermine protects intestinal barrier integrity through ras-related C3 botulinum toxin substrate 1/phospholipase C-γ1 signaling pathway in piglets
por: Liu, Guangmang, et al.
Publicado: (2021)

Ras-related C3 botulinum toxin substrate 1 (RAC1) regulates glucose-stimulated insulin secretion via modulation of F-actin
por: Asahara, S., et al.
Publicado: (2013)

Activation of cerebral Ras-related C3 botulinum toxin substrate (Rac) 1 promotes post-ischemic stroke functional recovery in aged mice
por: Bu, Fan, et al.
Publicado: (2023)

shRNA-induced silencing of Ras-related C3 botulinum toxin substrate 1 inhibits the proliferation of colon cancer cells through upregulation of BAD and downregulation of cyclin D1
por: Huang, You-Sheng, et al.
Publicado: (2018)

Silencing Ras-Related C3 Botulinum Toxin Substrate 1 Inhibits Growth and Migration of Hypopharyngeal Squamous Cell Carcinoma via the P38 Mitogen-Activated Protein Kinase Signaling Pathway
por: Cheng, Huijuan, et al.
Publicado: (2018)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy
por: Takeuchi, Masayoshi, et al.
Publicado: (2010)

Ras-Related C3 Botulinum Toxin Substrate 1 Combining With the Mixed Lineage Kinase 3- Mitogen-Activated Protein Kinase 7- c-Jun N-Terminal Kinase Signaling Module Accelerates Diabetic Nephropathy
por: Ying, Changjiang, et al.
Publicado: (2021)

Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson’s Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1)
por: Lu, Wusheng, et al.
Publicado: (2020)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Retracted: Overexpression of MicroRNA-133a Inhibits Apoptosis and Autophagy in a Cell Model of Parkinson’s Disease by Downregulating Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1)
por: Lu, Wusheng, et al.
Publicado: (2022)

Domperidone Inhibits Clostridium botulinum C2 Toxin and Bordetella pertussis Toxin
por: Jia, Jinfang, et al.
Publicado: (2023)

Botulinum as a Toxin for Treating Post-herpetic Neuralgia
por: DING, Xu-Dong, et al.
Publicado: (2017)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

Wound Modulation with Botulinum Toxin
por: Malik, Archana, et al.
Publicado: (2016)

Botulinum Toxin in the Treatment of Headache
por: Becker, Werner J.
Publicado: (2020)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Botulinum Toxin for Scalp Dysesthesia
por: Phan, Kevin, et al.
Publicado: (2022)

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Botulinum Toxin A for Treatment of Diaphragmatic Myoclonus
por: He, Yi-Jing, et al.
Publicado: (2017)

Cellular Entry of Clostridium perfringens Iota-Toxin and Clostridium botulinum C2 Toxin
por: Takehara, Masaya, et al.
Publicado: (2017)

Neutrophil-Derived Proteases Contribute to the Pathogenesis of Early Diabetic Retinopathy
por: Lessieur, Emma M., et al.
Publicado: (2021)

Retargeting the Clostridium botulinum C2 toxin to the neuronal cytosol
por: Pavlik, Benjamin J., et al.
Publicado: (2016)

The Multispecialty Toxin: A Literature Review of Botulinum Toxin
por: Bach, Karen, et al.
Publicado: (2022)

Botulinum toxin treatment for bielschowsky acquired commitant esotropia in adults
por: Ai, Likun, et al.
Publicado: (2022)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

The safety and efficacy of botulinum toxin A on the treatment of depression
por: Zhang, Qilin, et al.
Publicado: (2021)

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
por: Yang, Jing, et al.
Publicado: (2022)

Diabetic Retinopathy: From Pathogenesis to Treatment
por: Chakrabarti, Subrata
Publicado: (2007)

Role of Inflammation in the Pathogenesis of Diabetic Retinopathy
por: El-Asrar, Ahmed M. Abu
Publicado: (2012)

The Role of Lipoxidation in the Pathogenesis of Diabetic Retinopathy
por: Augustine, Josy, et al.
Publicado: (2021)

The role of aldosterone in the pathogenesis of diabetic retinopathy
por: Liu, Kangcheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s5v00r53e68kn987973kcfeic8